DGCI Approves for Phase III Trial of Bharat Biotech Intranasal Vaccine as Booster
New Delhi: The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted "in principle" approval to Bharat Biotech to conduct "Phase III superiority study and Phase III booster dose study" trials…